Method and activated lymphocyte preparations for preventing...

Details Method and activated lymphocyte preparations for preventing... Method and activated lymphocyte preparations for preventing...

2006-09-12

2006-09-12

Siew, Jeffrey (Department: 1642)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

C424S093700, C424S277100, C424S184100

Reexamination Certificate

active

07105155

ABSTRACT:
Activated lymphocytes are administered to a cancer patient at least five or more times within eight months after performing surgical and chemotherapeutic treatment or radiotherapy for treating cancer particularly liver cancer, so that recurrence of the cancer can be prevented over a long period of five or more years. The activated lymphocytes to be administered while performing treatment of cancer may be autologously derived from a cancer patient or collected from the other cancer patient at need. The activated lymphocytes can be cultivated for proliferating or activating lymphocyte cells collected in the presence of solid-phase anti-CD3 antigen and interleukin 2.

REFERENCES:
patent: 3-80076 (1991-04-01), None
Takayama et al, Sep. 2, 2000, The Lancet, 356: 802-807.
Sekine et al. 1994, Human cell, The Japan human cell socielty, 7(3): 121-124. English translated version.
Sasaki Y et al, J Hepato-biliary-pancreatic surgery, 1998, 5(1): 14-17.
Montesano, R et al, 1996, Intl J Cancer, 69(3): 225-235.
Burmer, GC et al, 1991, Environmental Health perspectives, 93: 27-31.
Busken, C et al, Digestive Disease Week Abstracts and Itinerary Planner, 2003, abstract No. 850.
Sekine T, 1994, Human cell: Official J human cell res society (Japan): 7(3):121-4.
Chakravarty, Ashim K, 1997, Current Science (Bangalore) 73(2): 201-203.
T. Takayama et al., “Adoptive Immunotherapy to Lower Postsurgical Recurrence Rates of Hepatocellular Carcinoma: a Randomised Trial”, The Lancet, vol. 356, No. 9232, Sep. 2, 2000, pp. 802-807.

Affiliated with

Also associated with

Rating

Method and activated lymphocyte preparations for preventing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and activated lymphocyte preparations for preventing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and activated lymphocyte preparations for preventing... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3600977